Interest has recently been focussed on the enzyme lysozyme as a result of the studies of Karl Meyer and his associates (1) (2) (3) (4) . They observed a much higher concentration of lysozyme in the stools of patients with ulcerative colitis than in those with normal colons or with other colonic disorders. In the gastric juice of subjects with peptic ulcer they found a less marked but apparently significant increase in lysozyme concentration above normal. From experimental observations in which was noted disappearance of the mucous coating in gastric pouches of dogs following the introduction of lysozyme these workers inferred that lysozyme attacked the protective layer of mucus investing the lining membrane of the stomach and colon. In experiments in vitro, however, they were unable to demonstrate such a lytic action on purified fractions of human gastric mucin. They did, however, induce experimentally gastrointestinal ulcerations in dogs by feeding them lysozyme in high concentration (1500 units or more per cc.). This concentration is higher than might be encountered in human pathologic processes (5).
The finding of increased lysozyme concentration in the stools of subjects with ulcerative colitis has been confirmed by Grossman (6) and by Grace and his associates (7) . The latter demonstrated in subjects with ulcerative colitis that the lysozyme titre in the stools paralleled not only the clinical state of ulcerative colitis but also the state of relative security of the subject in his life situation. During periods of remission, when stools were normal and the subject was relatively relaxed and secure, lysozyme values were normal. In reaction to situations of significant personal conflict lysozyme concentration rose. When such increases in lysozyme concentration were sustained 1 Aided by grants from the Commonwealth Fund and the Estate of Lester N. Hofheimer. for three or four days an episode of exacerbation of colitis with bloody stools and tenesmus ensued.
In the gastric juice of subjects with peptic ulcer confirmation of Meyer's findings has been less clear cut. Grossman (6) Eight series of tests were performed on gastric mucus of which four were done on mucus from source I, two on mucus from source II, and one each on mucus from sources III and IV. The results are recorded in Figures  1-3 and Tables I and II. In addition to these tests the results of three series of tests on mucus from source I are recorded in Table III .
In addition to data reported here, seven series of tests were performed on gastric mucus from sources I-IV. These tests were not altogether complete, but the data they did yield were all in conformity with the results reported here. Native gastric mucus collected as described under Sources (II) and prepared as described under Preparations (E).
To three samples of this preparation, 2 cc. each, were added respectively: 0.5 cc. distilled water, 0.5 cc. solution containing 1.5 mgm. egg white lysozyme, and 0.5 cc. 30% solution of human tears in water. Incubation at pH 7.0 and 370 C. The mucoproteose content was determined after 24 hours of incubation.
Results

By none of the procedures outlined was it pos-
A. Effect of lysozyme on gastric mucus is shown sible to demonstrate any mucolytic action of lysoin data listed in Tables I and II and Figures zyme on gastric mucus or its constituents even  1-3. under optimal conditions for lysozyme activity. tested against controls (buffer solution) and against the standard Micrococcus lysodeikticus substrate. These data listed in Table III demonstrate that addition of gastric mucus does not decrease the activity of lysozyme upon its bacterial substrate (Micrococcus lysodeikticus). On the contrary some tests indicated a slight increase in lysozyme action after incubation for 24 hours with mucus which was greater than could be accounted for by the small amount of lysozyme present in the gastric mucus.
Comment: These observations establish further the lack of evidence of interaction between gastric mucus and lysozyme even under optimal pH and temperature conditions. If gastric mucus were in fact a substrate for lysozyme, one would have expected some of the lysozyme to have been "used up" during the incubation procedure.
COLONIC MUCUS
Sources
Colonic mucus was obtained directly from exposed loops of colon of two fistulous subjects described elsewhere in detail (12) . One of these subjects had a normal colon. The other had ulcerative colitis.
Preparations
Samples from both subjects were treated by the methods described above under A, C, and E, for gastric mucus.
Testing procedures
These included viscosimetric determinations by the method of Meyer and Hahnel (11) (1) .
The lack of mucolytic effect of lysozyme in vitro on colonic mucus would also indicate that lysozyme cannot be considered a solvent agent for the mucus of the human colon.
The question of direct mucosal damage from lysozyme cannot be answered by the above data, but it should be noted that the only actual mucosal ulceration which has been produced experimentally required the feeding or infusion of a concentration of lysozyme far greater than that encountered in the human stomach or colon even under pathologic conditions. Further experiments are necessary to establish whether or not lysozyme in physiologic concentrations is actually capable of destroying or initiating destruction of mucosal cells.
One possible explanation of the striking correlation of elevated lysozyme concentration with ulcerations in ulcerative colitis is that the lysozyme may be elaborated as part of the biologic pattern of defense of the human organism directed chiefly against the possibility of bacterial invasion. The bacteriolytic properties of lysozyme were first recognized by Fleming et al. (13, 14) and are easily demonstrated. More recent data on the relation of lysozyme to bacteriophage would support this inference (15) . Possibly, the increased secretion, or excretion of lysozyme into the colon during periods of emotional conflict preceding and accompanying an exacerbation of ulcerative colitis (7) may be related to the associated engorgement of the colonic mucosa.
SUMMARY AND CONCLUSIONS
Lysozyme from a human source (tears) and purified egg White lysozyme have been tested against various preparations of human gastric and colonic mucus by the viscosimetric method of Meyer and Hahnel and by chemical analyses for the products of mucin digestion (mucoproteose).
Neither whole gastric or colonic mucus from fistulous human subjects or its various preparations at optimal pH values, nor any of the purified constituents of gastric mucus were measurably dissolved or digested by egg white lysozyme or human tear lysozyme. This was true not only of mucin obtained from aspirated fluids but also of the mucinous coating removed directly from the mucous membrane of the stomach and colon. Conversely, contact of lysozyme with gastric mucus did not impair the activity of the lysozyme on its mucinous bacterial substrate (Micrococcus lysodeikticus).
In gastric mucus an autolytic process was noted at a neutral or slightly alkaline pH. Since this action was not affected by addition of either lysozyme or pepsin it seems likely that it is due to the presence of another mucolytic agent (enzyme?) which acts at a neutral range of pH and which may be involved in the physiological process of mucolysis in the human stomach under these conditions.
These observations lead to the inference that whatever are the consequences of increased lysozyme secretion in ulcerative colitis, they do not include digestion of the protective layer of colonic mucus. Neither does lysozyme attack the protective mucous coating of the stomach, not contribute to the formation of peptic ulcer by virtue of its dissolving or splitting action on the gastric mucus. 
